Evidence map›Paper›PMID 29396424›Full record

ArticleCell death & disease2018

Inactivation of ribosomal protein S27-like confers radiosensitivity via the Mdm2-p53 and Mdm2-MRN-ATM axes.

Yongchao Zhao, Mingjia Tan, Xia Liu, Xiufang Xiong, Yi Sun

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. iASPP mediates p53 selectivity through a modular mechanism fine-tuning DNA recognition.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  13. Article
  14. Article
  15. Translation Control byCancers · 2018
    Article
  16. Screening of Long Noncoding RNAs Induced by Radiation Using Microarray.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Yongchao ZhaoInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. yongchao@zju.edu.cn.
Mingjia TanDivision of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Xia LiuInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China.
Xiufang XiongInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. xiufang@zju.edu.cn.
Yi SunInstitute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, China. yisun@zju.edu.cn.
Zhejiang University · CNUniversity of Michigan–Ann Arbor · US

Funding

The role of FBXW2 as a novel lung tumor suppressor that cross-talks with oncogenic beta-TrCP and SKP2R01CA156744 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORGAN, MEREDITH A · 2011 to 2020
$3.4M
NCI NIH HHS R01 CA156744
6 · The paper itself

Abstract

RPS27L (ribosomal protein S27-like) is an evolutionarily conserved ribosomal protein and a direct p53 target. We recently reported that Rps27l disruption triggers ribosomal stress to induce p53, causing postnatal death, which can be rescued by Trp53

Indexed as

Radiation ToleranceSignal TransductionAnimalsApoptosisAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell ProliferationDNA-Binding ProteinsDNA DamageMiceModels, BiologicalMultiprotein ComplexesNuclear ProteinsProtein BindingProto-Oncogene Proteins c-mdm2Ribosomal ProteinsAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsDNA-Binding ProteinsMultiprotein ComplexesNijmegen breakage syndrome 1 protein, mouseNuclear ProteinsProto-Oncogene Proteins c-mdm2Ribosomal ProteinsRps27l protein, mouseTumor Suppressor Protein p53

Identifiers

PMID29396424
PMCPMC5833388
OpenAlexW2792869944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.